Abbreviations
- GBS:
-
Guillain–Barré syndrome
- FD:
-
Facial diplegia
- IgG:
-
Immunoglobulin G
- PA:
-
Phosphatidic acid
- CSF:
-
Cerebrospinal fluid
References
Yuki N, Hartung HP (2012) Guillain–Barré syndrome. N Engl J Med 366:2294–2304
Wakerley BR, Unici A, Yuki N (2014) GBS classification group. Guillain–Barré and Miller Fisher syndromes—new diagnostic classification. Nat Rev Neurol 10:537–544
Tan EK, Lim SH, Wong MC, Chan LL (1999) Facial diplegia: cranial variant of Guillain–Barré syndrome? J R Soc Med 92:26–27
Susuki K, Koga M, Hirata K, Isogai E, Yuki N (2009) A Guillain–Barré syndrome variant with prominent facial diplegia. J Neurol 256:1899–1905
Kim JK, Oh SY, Shon EH, Hong YH, Jun SM, Bae JS (2015) When is facial diplegia regarded as a variant of Guillain–Barré syndrome? J Peripher Nerv Syst 20:32–36
Wakerley BR, Yuki N (2015) Isolated facial diplegia in Guillain–Barré syndrome: bifacial weakness with paresthesias. Muscle Nerve 52:927–932
Kusunoki S, Morita D, Ohminami S, Hitoshi S, Kanazawa I (2003) Binding of immunoglobulin G antibodies in Guillain–Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications. Muscle Nerve 27:302–306
Kim JK, Bae JS, Kim DS, Kusunoki S, Kim JE, Kim JS et al (2014) Prevalence of anti-ganglioside antibodies and their clinical correlates with Guillain–Barré syndrome in Korea: A Nationwide Multicenter Study. J Clin Neurol 10:94–100
Acknowledgements
We would like to thank Professor Susumu Kusunoki (Department of Neurology, Kinki University School of Medicine, Osaka) for measuring anti-ganglioside antibodies and all members of the Department of Neurology at Japanese Red Cross Kumamoto Hospital for helping with the collection of clinical data.
Funding
This study was supported by the Ministry of Health, Labor, and Welfare, Japan and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (JSPS KAKENHI Grant Number 19H03549).
Author information
Authors and Affiliations
Contributions
KN contributed to study conception and design, collected the data, drafted the manuscript for intellectual content. SN contributed to study conception and design, interpreted the data, drafted the manuscript for intellectual content. TT interpreted the data, drafted the manuscript for intellectual content. YA interpreted the data, drafted the manuscript for intellectual content.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Ethical approval
To ensure confidentiality and anonymity of our patient, only clinical data are presented.
Consent for publication
The patient has given his informed consent.
Data availability
All data related to this case report are contained within the manuscript.
Code availability
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nakahara, K., Nakane, S., Terasaki, T. et al. Effect of phosphatidic acid on antiganglioside antibody reactivity in the isolated facial diplegia variant of Guillain–Barré syndrome: a case report. Acta Neurol Belg 123, 231–232 (2023). https://doi.org/10.1007/s13760-020-01592-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13760-020-01592-z